Clinical research
Clinical trial sites in the United Kingdom
Clinical trial sites: one pin for each physical site that hosts trials, placed from the address on the trial registration.
- Trial site
- Group of pins (click to zoom)
Showing 32,416 located sites.
Each pin is one trial site, placed on the map from the address on the trial registration, so it shows part of where trials are run, not all of it. A site with no located address has no pin. A site with a public page on Pharma Observatory links to it; other sites show name, place and trial count only.
Looking for contract research suppliers and CROs? Visit Contract Research Map
Looking to track new and ongoing clinical trials? Visit Trial Insights
Trial sites by region
Select a bar to filter by region.
Log scale: bar lengths compare orders of magnitude, not proportions.
| Category | Trial sites |
|---|---|
| Europe | 32,416 |
Top countries
Country of the site's address. Select a bar to filter.
Log scale: bar lengths compare orders of magnitude, not proportions.
Bar colour shows the country's region, as in the chart by region.
| Category | Trial sites |
|---|---|
| United States | 307,205 |
| France | 73,197 |
| Germany | 73,176 |
| Italy | 48,496 |
| China | 45,975 |
| Japan | 38,756 |
| Spain | 36,445 |
| United Kingdom | 32,416 |
Trial sites
32,416 sites. Sites with a public page link to it on Pharma Observatory.
-
Site GB44024 1 trial
-
Site GB44024 St James's University Hospital 1 trial
-
Site GB44025 1 trial
-
Site GB44025 Kings College Hospital 1 trial
-
Site GB44026 1 trial
-
Site GB4403 1 trial
-
Site GB44031 1 trial
-
Site GB44032 1 trial
-
Site GB4405 1 trial
-
Site GB4406 1 trial
-
Site GB44064 1 trial
-
Site GB4407 1 trial
-
Site GB44079 1 trial
-
Site GB4408 1 trial
-
Site GB44080 1 trial
-
Site GB44080 1 trial
-
Site GB44082 1 trial
-
Site GB44086 1 trial
-
Site GB44087 1 trial
-
Site GB44097 1 trial
Explore the data behind the map on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.